title: [Peginterferon alpha-2a and ribavirin for treating chronic hepatitis C patients with persistent normal aminotransferase levels].
authors.affiliation: First Department of Infectious Diseases, PLA 302 Hospital, Beijing 100039, China. drjtj@sina.com
authors.forename: Tian-jun
authors.initials: TJ
authors.lastname: Jiang
authors.forename: Rong
authors.initials: R
authors.lastname: Fan
authors.forename: Yang-xin
authors.initials: YX
authors.lastname: Xie
authors.forename: Peng
authors.initials: P
authors.lastname: Zhao
authors.forename: Xin
authors.initials: X
authors.lastname: Zhang
authors.forename: Min
authors.initials: M
authors.lastname: Zhao
authors.forename: Zhi-ping
authors.initials: ZP
authors.lastname: Zhou
authors.forename: Jing
authors.initials: J
authors.lastname: He
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D000637:Transaminases / Q000097:blood; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D000637:Transaminases; C100416:peginterferon alfa-2a